Deerfield Management’s Autolus Therapeutics AUTL Stock Holding History

Deerfield Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,639,000	Closed	-$13.2M	–	142
2024 Q3	$13.2M	Hold	3,639,000	–	–	0.2%	63
2024 Q2	$12.7M	Hold	3,639,000	–	–	0.21%	62
2024 Q1	$23.2M	Buy	+3,639,000	New	+$22.7M	0.4%	47
2021 Q2	–	Sell	-2,142,857	Closed	-$12.3M	–	144
2021 Q1	$12.3M	Buy	+2,142,857	New	+$15.9M	0.26%	91
2019 Q1	–	Sell	-235,576	Closed	-$7.74M	–	95
2018 Q4	$7.74M	Sell	235,576 -14,424	-6%	-$475K	0.31%	68
2018 Q3	$7.67M	Hold	250,000	–	–	0.27%	80
2018 Q2	$6.7M	Buy	+250,000	New	+$6.61M	0.24%	91

Other funds holding AUTL

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return